SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2011 Biotech Charity Contest
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ghmm who wrote (382)1/2/2012 7:45:06 PM
From: Arthur Radley   of 400
 
If not a trick question then I remove GE from the list. The reason I credited GE was that it was one of their employees that developed a petroleum application that was created via biotechnology....it took a Supreme Court ruling to validate their patent, thus making the biotech industry viable(1980's). It was around this court ruling that AMGN became a public company with the famous George Rathmann leading the company. However, for the first few years AMGN was a single digit stock and only broke into double digits several years into operation as a public company. It was in late 1989 that Epogen was approved by the FDA--so considering that on 2/3/89 the volume jumped to 40 million shares and stock was now trading over $40.00--my guess is that AMGN is the answer to your question. One other that I might consider is Immunex, but now it's own by AMGN and digging back in their records isn't as easy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News